Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,471 signal articles · 165 in last 24h · 116,526 total before filter · latest 59m ago
165last 24h
1719last 7d
282● bullish (7d)
155● bearish (7d)
205publishers
AllMacro320Earnings777M&A101Regulatory24Product16Analyst24
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?
Insider Monkey6d agobullish
Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?

Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS of $2.80 exceeding expectations by $0.30. Despite that, the stock plunged due to mounting concerns about slowing domestic procedure growth. Worldwide procedures, da Vinci and Ion […]

Rocket Lab’s (NASDAQ:RKLB) Q2 CY2026: Beats On Revenue, Provides Optimistic Revenue Guidance for Next Quarter
StockStory6d agobullish
Rocket Lab’s (NASDAQ:RKLB) Q2 CY2026: Beats On Revenue, Provides Optimistic Revenue Guidance for Next Quarter

Aerospace and defense company Rocket Lab (NASDAQ:RKLB) announced better-than-expected revenue in Q2 CY2026, with sales up 62% year on year to $234.1 million. On top of that, next quarter’s revenue guidance ($257.5 million at the midpoint) was surprisingly good and 7% above what analysts were expecting. Its GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
Insider Monkey6d agoneutral
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts’ average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised its guidance and stated that it is on track to meet […]

Investing.com6d agobullish
Plug Power beats revenue estimates, raises guidance

Investing.com -- Plug Power Inc. (NASDAQ:PLUG) reported second quarter results that exceeded analyst expectations, with revenue of $178.3 million surpassing the consensus estimate of $168.76 million. The hydrogen solutions provider posted adjusted earnings per share of -$0.07, beating the analyst estimate of -$0.08.